Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors | Journal for ImmunoTherapy of Cancer

Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Close More
Main menu

Latest content

Browse by collection

Archive

Authors

About
Log in More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
BMJ Journals

Article metrics

PDF +
Supplementary
Material

Basic tumor immunology

Original research

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors

Online download statistics by month:

Online download statistics by month: June 2022 to March 2024

	Abstract	Full	Pdf
Jun 2022	283	287	58
Jul 2022	389	395	148
Aug 2022	232	234	51
Sep 2022	216	222	65
Oct 2022	279	284	60
Nov 2022	263	270	85
Dec 2022	173	174	62
Jan 2023	133	134	39
Feb 2023	157	161	85
Mar 2023	158	160	65
Apr 2023	129	140	48
May 2023	125	127	65
Jun 2023	138	141	69
Jul 2023	113	113	75
Aug 2023	96	96	53
Sep 2023	96	99	53
Oct 2023	138	139	84
Nov 2023	142	143	78
Dec 2023	147	147	66
Jan 2024	97	98	60
Feb 2024	137	137	40
Mar 2024	146	149	67
Total	3787	3850	1476